Life SciencesDiagnosticsIn Vitro DiagnosticsBlood Banking & Tissue Typing

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $1,700 109 Pages Koncept Analytics July, 2019 KOAN16001429
Lowest Prices Guaranteed
Price from $1,700
Length 109 Pages
Publisher Koncept Analytics
Published Date July, 2019
SKU KOAN16001429

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

The global blood plasma market is estimated to reach US$29.50 billion in 2023, growing at a CAGR of 7% for the period spanning from 2019 to 2023. The factors such as progress in therapeutic protein development, new advances in production of plasma, growing aging population, increasing spending on medicines and rise in collection centers are expected to drive the market. However, growth of the industry will be challenged by high cost of treatment, and high R&D costs. A few notable trends include increase in fractionation capacity, and innovation in therapeutics.

The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment.

North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States.

Scope of the report:

  • The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others.
  • The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail.
Key Target Audience:
  • Blood Plasma Products Manufacturers
  • End Users (Hospitals, Medical Centers & Clinical Institutes)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities


1. Market Overview
1.1 Blood Plasma
Table 1: Components of Blood Plasma
1.2 Blood Plasma Fractionation Process
Table 2: Blood Plasma Fractionation Process
1.3 Blood Plasma Derivatives
Table 3: Blood Plasma Protein Breakup
1.4 Functions of Blood Plasma
Table 4: Functions of Blood Plasma
1.5 Plasma Collection
Table 5: Plasma Fractioned to Protein
2. Global Market Analysis
2.1 Global Blood Plasma Market by Value
Table 6: Global Blood Plasma Market by Value (2014-2018)
2.2 Global Blood Plasma Market Forecast by Value
Table 7: Global Blood Plasma Market Forecast by Value (2019-2023)
2.3 Global Blood Plasma Fractionation Capacity
Table 8: Global Blood Plasma Fractionation Capacity (2014-2018)
2.4 Global Blood Plasma Fractionation Capacity Forecast
Table 9: Global Blood Plasma Fractionation Capacity Forecast (2019-2023)
2.5 Global Blood Plasma Fractionation Capacity by Type
Table 10: Global Blood Plasma Fractionation Capacity by Type (2014-2018)
2.6 Global Blood Plasma Fractionation Capacity Forecast by Type
Table 11: Global Blood Plasma Fractionation Capacity Forecast by Type (2019-2023)
2.7 Global Blood Plasma Market by Type
Table 12: Global Blood Plasma Market by Type (2018)
2.8 Global Blood Plasma Market Forecast by Type
Table 13: Global Blood Plasma Market Forecast by Type (2023)
2.9 Global Immunoglobulin Market
2.9.1 Global Immunoglobulin Market Forecast by Value
Table 14: Global Immunoglobulin Market Forecast by Value (2018-2023)
2.9.2 Global Immunoglobulin Market Forecast by Volume
Table 15: Global Immunoglobulin Market Forecast by Volume (2018-2023)
2.9.3 Global Immunoglobulin Market Volume by Region
Table 16: Global Immunoglobulin Market Volume by Region (2018)
2.9.4 Global Immunoglobulin Market by Types
Table 17: Global Immunoglobulin Market by Types (2018)
2.9.5 Global Immunoglobulin Population by Indication
Table 18: Global Immunoglobulin Population by Indication (2018)
2.10 Global Albumin Market
2.10.1 Global Albumin Market Forecast by Value
Table 19: Global Albumin Market Forecast by Value (2018-2023)
2.10.2 Global Albumin Market Forecast by Volume
Table 20: Global Albumin Market Forecast by Volume (2018-2023)
2.10.3 Global Albumin Market Volume by Region
Table 21: Global Albumin Market Volume by Region (2018)
2.11 Global Factor VIII Market
2.11.1 Global Factor VIII Market Forecast by Value
Table 22: Global Factor VIII Market Forecast by Value (2018-2023)
2.11.2 Global Factor VIII Market Forecast by Volume
Table 23: Global Factor VIII Market Forecast by Volume (2018-2023)
2.12 Global Alpha 1 Market
2.12.1 Global Alpha 1 Market Forecast by Value
Table 24: Global Alpha 1 Market Forecast by Value (2018-2023)
2.13 Global Blood Plasma Market by Region
Table 25: Global Blood Plasma Market by Region (2018)
3. Regional Analysis
3.1 North America
3.1.1 North America Blood Plasma Market Forecast by Value
Table 26: North America Blood Plasma Market Forecast by Value (2018-2023)
3.1.2 North America Blood Plasma Market by Type
Table 27: North America Blood Plasma Market by Type (2018)
3.1.3 The US Immunoglobulin Market Forecast by Value & Volume
Table 28: The US Immunoglobulin Market Forecast by Value & Volume (2018-2023)
3.1.4 The US Immunoglobulin Market Volume by Segment
Table 29: The US Immunoglobulin Market Volume by Segment (2018)
3.1.5 The US Albumin Market Forecast by Volume
Table 30: The US Albumin Market Forecast by Volume (2018-2023)
3.1.6 The US Source Plasma Collection Volume
Table 31: The US Source Plasma Collection Volume (2014-2018)
3.1.7 The US Source Plasma Collection Volume Forecast
Table 32: The US Source Plasma Collection Volume Forecast (2019-2023)
3.2 Europe
3.2.1 Europe Blood Plasma Market Forecast by Value
Table 33: Europe Blood Plasma Market Forecast by Value (2018-2023)
3.3 APAC
3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value
Table 34: Asia-Pacific Blood Plasma Market Forecast by Value (2018-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Recent Progress in Therapeutic Protein Drug Development
Table 35: Protein Engineering Platform Technologies (2018)
4.1.2 Developments in the Production of Plasma Derivatives
Table 36: The US Food and Drug Administration-Approved IG Products (2018)
4.1.3 Increasing Plasma Collection
Table 37: Plasma Collection in the US (2014-2018)
4.1.4 Increase in Per Capita use of Immunoglobulin
Table 38: Per Capita use of Immunoglobulin by Region (2018)
4.1.5 Rise in GDP Per Capita
Table 39: Global GDP Per Capita (2014-2018)
4.1.6 Increased Spending on Medicines
Table 40: Global Spending on Medicines (2010-2020)
4.1.7 Increasing Global Healthcare Expenditure
Table 41: Global Healthcare Expenditure (2014-2018)
4.1.8 Escalating Ageing Population
Table 42: Global Ageing Population of 60 Years or Older (2014-2018)
4.2 Trends & Developments
4.2.1 Increasing Fractionation Capacity
Table 43: Fractionation Capacity of Key Market Players (2013-2022)
4.2.2 Growing Blood Plasma Market in Emerging Economies
4.3 Challenges & Issues
4.3.1 High Barriers to Entry
4.3.2 Challenging to Open New Plasma Centers
4.3.3 High R&D Costs
5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
Table 44: Key Players - Revenue & Market Cap Comparison (2018)
5.1.2 Research & Development Expenditure Comparison
Table 45: Key Players - Research & Development Expenditure Comparison (2018)
5.1.3 Global Blood Plasma Market Share
Table 46: Global Blood Plasma Market Share by Company (2018)
5.1.4 Global Immunoglobulin Market Share
Table 47: Global Immunoglobulin Market Share by Company (2018)
5.1.5 Global Albumin Market Share
Table 48: Global Albumin Market Share by Company (2018)
5.1.6 Global Plasma-Derived Factor VIII Market Share
Table 49: Global Plasma-Derived Factor VIII Market Share by Company (2018)
5.1.7 Global Alpha1 Market Share
Table 50: Global Alpha1 Market Share by Company (2018)
5.1.8 Growth in Plasma Collection by Leading Players
Table 51: Growth in Plasma Collection by Leading Players (2014-2018)
5.2 The US
5.2.1 The US Blood Plasma Collection Centers by Major Players
Table 52: The US Blood Plasma Collection Centers by Major Players (2014-2018)
5.2.2 The US Blood Plasma Collection Volume by Major Players
Table 53: The US Blood Plasma Collection Volume by Major Players (2014-2018)
6. Company Profiles
6.1 Takeda Pharmaceutical (Shire Plc.)
6.1.1 Business Overview
6.1.2 Financial Overview
Table 54: Takeda Pharmaceutical Revenue Share by Product (2019)
Table 55: Takeda Pharmaceutical Revenue Share by Geographic Region (2019)
Table 56: Takeda Pharmaceutical Revenue and Net Profit (2015-2019)
6.1.3 Business Strategies
6.2 CSL Limited
6.2.1 Business Overview
6.2.2 Financial Overview
Table 57: CSL Limited Revenue Share by Segments (2018)
Table 58: CSL Limited Sales and Net Profit (2014-2018)
6.2.3 Business Strategies
6.3 Grifols, S.A.
6.3.1 Business Overview
6.3.2 Financial Overview
Table 59: Grifols, S.A. Revenue Share by Business Segments (2018)
Table 60: Grifols, S.A. Revenue Share by Geographic Region (2018)
Table 61: Grifols, S.A. Revenue and Profit (2014-2018)
6.3.3 Business Strategies
6.4 Octapharma, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
Table 62: Octapharma, Inc. Revenue and Net Profit (2014-2018)
6.4.3 Business Strategies
6.5 ADMA Biologics, Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
Table 63: ADMA Biologics Revenue Share by Business Segments (2018)
Table 64: ADMA Biologics Revenue and Net Loss (2014-2018)
6.5.3 Business Strategies
6.6 China Biologics Product Holdings
6.6.1 Business Overview
6.6.2 Financial Overview
Table 65: China Biologics Revenue Share by Business Segments (2018)
Table 66: China Biologics Revenue and Net Income (2014-2018)
6.6.3 Business Strategies

$1,700
$2,300
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks